Immunotech Biopharm Ltd (6978.HK)

HKD 2.47

(8.33%)

Total Debt Summary of Immunotech Biopharm Ltd

Immunotech Biopharm Ltd's latest annual total debt in 2023 was 457.17 Million CNY , up 205.18% from previous year.
Immunotech Biopharm Ltd's latest quarterly total debt in 2024 Q1 was 285.79 Million CNY , down -37.49% from previous quarter.
Immunotech Biopharm Ltd reported annual total debt of 149.8 Million CNY in 2022, up 34.89% from previous year.
Immunotech Biopharm Ltd reported annual total debt of 111.05 Million CNY in 2021, up 117.5% from previous year.
Immunotech Biopharm Ltd reported quarterly total debt of 285.79 Million CNY for 2024 Q1, down -37.49% from previous quarter.
Immunotech Biopharm Ltd reported quarterly total debt of 461.18 Million CNY for 2023 Q2, up 5.78% from previous quarter.

Annual Total Debt Chart of Immunotech Biopharm Ltd (2023 - 2018)

Historical Annual Total Debt of Immunotech Biopharm Ltd (2023 - 2018)

Year	Total Debt	Total Debt Growth
2023	457.17 Million CNY	205.18%
2022	149.8 Million CNY	34.89%
2021	111.05 Million CNY	117.5%
2020	51.06 Million CNY	30.92%
2019	39 Million CNY	15.2%
2018	33.85 Million CNY	0.0%

Year	Total Debt	Total Debt Growth
2024 Q2	285.79 Million CNY	43.22%
2024 Q1	285.79 Million CNY	-37.49%
2023 Q2	461.18 Million CNY	5.78%
2023 FY	457.17 Million CNY	205.18%
2023 Q1	435.98 Million CNY	191.04%
2023 Q4	457.17 Million CNY	5.71%
2023 Q3	432.49 Million CNY	-6.22%
2022 Q4	149.8 Million CNY	21.06%
2022 Q3	123.75 Million CNY	22.08%
2022 Q2	101.36 Million CNY	27.37%
2022 Q1	79.58 Million CNY	-28.34%
2022 FY	149.8 Million CNY	34.89%
2021 Q1	43.67 Million CNY	-14.47%
2021 Q2	52.65 Million CNY	20.56%
2021 FY	111.05 Million CNY	117.5%
2021 Q4	111.05 Million CNY	22.25%
2021 Q3	90.84 Million CNY	72.53%
2020 Q4	51.06 Million CNY	16.43%
2020 FY	51.06 Million CNY	30.92%
2020 Q3	43.85 Million CNY	18.46%
2020 Q2	37.02 Million CNY	11.16%
2020 Q1	33.3 Million CNY	-14.6%
2019 Q3	35.21 Million CNY	0.0%
2019 Q1	- CNY	0.0%
2019 Q4	39 Million CNY	10.75%
2019 FY	39 Million CNY	15.2%
2018 FY	33.85 Million CNY	0.0%

Peer Total Debt Comparison of Immunotech Biopharm Ltd

Name	Total Debt	Total Debt Difference
Uni-Bio Science Group Limited	52.86 Million HKD	-764.761%
CK Life Sciences Int'l., (Holdings) Inc.	5.93 Billion HKD	92.292%